gsk glp-1 Emerging Frontiers in Therapeutics: A Comprehensive Evidence Base (2025) GLP-1 Updates for Employers: Demand,

Lu SC: Regulation of hepatic glutathione synthesis: current concepts and controversies

71 Table 2 lists commonly accepted indications for treatment with NAC in the setting of acute over-ingestion

A review highlights the potential benefits of GLP-1 receptor agonists in managing various aspects of PCOS, including insulin resistance, hyperandrogenism, and ovulatory dysfunction

Sinai Hospital, Toronto, Canada summarize and elucidate evidence that glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), initially developed for the treatment of type 2 diabetes and weight management, demonstrate a surprisingly broad range of clinical benefits